In 2021, TIMI-authored papers received a total of 25,224 citations. All-time citations at the end of 2021 exceeded 308,000, with an H-index of 271.
Top Papers Cited in 2021, Published Anytime
836 Citations – Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019 Jan 24;380(4):347-357.
466 Citations – Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med. 2017 May 4;376(18):1713-1722.
382 Citations – Edoxaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2013 Nov 28;369(22):2093-104.
Hot Papers Published in 2020, Cited in 2021
TIMI Publications and Times Cited Over Time
